R.PR
REGISTERED-PRINCIPAL REGISTER
04/05/2022
Back to search
Official data from USPTO
TARGET RWE HEALTH EVIDENCE SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/05/2022
Trademark type
Combined
Nice classes
35, 42, 45
Filing date
08/24/2020
Registration date
04/05/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/05/2022
Last transaction
04/05/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/09/2020
First use in commerce
08/09/2020
Drawing code
3
Owner type
03
Owner location
Durham, NC, US
Examiner
NEPTUNE, EVONNE
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "TARGET RWE" in a stylized font above a horizontal line over the words "HEALTH EVIDENCE SOLUTIONS" in a stylized font. All wording is to the right of a stylized, twisted knot.
Holders and representatives
Holders
Target PharmaSolutions, Inc.
Representatives
Shaun J. Bockert BLANK ROME LLP
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Marketing consulting services for companies in the life sciences industry relating to post-marketing drug safety and surveillance; Business services provided to the life sciences industrythe collectionreportinganalysis of healthcare quality data for business purposes; Data processing services in the field of post-marketing drug safety and surveillance
Class 42
Scientific research consulting services for companies in the life sciences industry relating to post-marketing drug safety and surveillance; Providing medical and scientific research information in the field of pharmaceuticals; Clinical research and testing services in the fields of pharmaceuticals; Product development consultation in the fields of pharmaceuticals; Consulting services in the field of pharmaceutical research; Medical and scientific research in the field of post-marketing drug safety and surveillance; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research in the field of pharmaceuticals
Class 45
Regulatory compliance consulting services for companies in the life sciences industry relating to post-marketing drug safety and surveillance
Publications
History of USPTO decisions and trademark events.
31 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/03/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/02/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/19/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/19/2021
ALIE
ASSIGNED TO LIE
11/17/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/12/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/11/2021
GNRT
NON-FINAL ACTION E-MAILED
10/11/2021
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/11/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/07/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/19/2021
IUAF
USE AMENDMENT FILED
07/07/2021
EISU
TEAS STATEMENT OF USE RECEIVED
07/07/2021
DOCK
ASSIGNED TO EXAMINER
06/02/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/06/2021
PUBO
PUBLISHED FOR OPPOSITION
04/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/27/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/26/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/05/2021
GNRT
NON-FINAL ACTION E-MAILED
01/05/2021
CNRT
NON-FINAL ACTION WRITTEN
01/05/2021
DOCK
ASSIGNED TO EXAMINER
12/20/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/29/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/28/2020
NWAP
NEW APPLICATION ENTERED
08/27/2020
Continuous trademark protection
Get notified about every new filing that threatens TARGET RWE HEALTH EVIDENCE SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.